TRIVARX LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.026 AUD | 0.00% |
|
+8.33% | -13.33% |
| Feb. 28 | TrivarX Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
| Feb. 09 | TrivarX Signs Collaboration with Northern Michigan University on Sleep Research | MT |
Quotes 5-day view
End-of-day quote Australian S.E.| 2024-04-19 | 2024-04-22 | 2024-04-23 | 2024-04-24 | 2024-04-26 | |
|---|---|---|---|---|---|
| Last | 0.024 $ | 0.024 $ | 0.025 $ | 0.026 $ | 0.026 $ |
| Volume | 213 413 | 550 000 | 414 847 | 66 587 | 2 035 518 |
| Change | +∞% | 0.00% | +4.17% | +4.00% | 0.00% |
| Opening | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 |
| High | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 |
| Low | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 |
Performance
| 1 week | +8.33% | ||
| Current month | -10.34% | ||
| 1 month | -10.34% | ||
| 3 months | -3.70% | ||
| 6 months | +18.18% | ||
| Current year | -13.33% | ||
| 1 year | +30.00% | ||
| 3 years | -81.43% | ||
| 5 years | -92.78% | ||
| 10 years | -99.57% |
Volumes
marketsDaily volume
2 035 518
Avg. Volume 20 sessions
446 732
Avg. Volume 20 sessions AUD
11 615.03
Avg. Volume 20 sessions USD
7 627.13
Record volume 1
5 079 485
Record volume 2
5 034 845
Record volume 3
4 899 451
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (AUD)
8 739 943
Capitalization (USD)
5 739 171
Net sales (AUD)
960 451
Net sales (USD)
630 690
Free-Float
71.74 %
Free-Float capitalization (AUD)
6 262 392
Free-Float capitalization (USD)
4 112 263
Average Daily Capital Traded
0.13%
Highs and lows
1 week
0.02
0.03
1 month
0.020.03
Current year
0.020.04
1 year
0.020.04
3 years
0.020.26
5 years
0.020.64
10 years
0.0210.50
Indicators
Moving average 5 days
0.03
Moving average 20 days
0.03
Moving average 50 days
0.03
Moving average 100 days
0.03
Price spread / (MMA5)
+15.38%
Price spread / (MMA20)
+15.38%
Price spread / (MMA50)
+15.38%
Price spread / (MMA100)
+15.38%
STIM
RSI 9 days
51.23
RSI 14 days
47.68
Sector Comparison - Specialty & Advanced Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| 0.00% | +8.33% | -13.33% | +30.00% | 5.74M | ||
| +1.10% | +3.94% | +5.31% | -6.64% | 70.44B | ||
| +0.23% | +0.80% | +10.97% | -12.91% | 8.94B | ||
| +0.24% | +0.97% | -16.83% | +21.01% | 4.75B | ||
| +4.34% | +23.11% | +43.48% | +109.09% | 4.5B | ||
| -0.70% | +2.45% | +3.20% | +29.43% | 3.85B | ||
| +3.66% | +12.49% | -21.36% | -40.50% | 2.34B | ||
| +0.05% | -4.81% | -29.67% | -45.78% | 2.2B | ||
| -0.66% | +1.14% | +8.38% | -21.00% | 1.96B | ||
| +2.59% | +2.28% | +3.90% | -18.42% | 1.65B | ||
| -.--% | -.--% | - | - | 1.64B | ||
| +0.82% | +7.56% | +1.14% | -12.25% | 1.25B | ||
| +1.41% | +4.82% | +16.02% | +30.46% | 1.01B | ||
| +1.54% | +16.53% | -24.30% | -27.93% | 981M | ||
| +1.82% | +4.19% | -37.08% | -49.99% | 880M | ||
| 0.00% | +7.66% | +31.02% | +42.45% | 838M | ||
| Average | +1.03% | +4.34% | -1.28% | +1.80% | ||
| Weighted average by Cap. | +1.07% | +3.87% | +4.69% | -1.58% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -13.33% | ||
| 2023 | -25.00% | ||
| 2022 | -63.64% | ||
| 2021 | -31.25% | ||
| 2020 | -20.00% | ||
| 2019 | -52.38% | ||
| 2018 | -93.91% | ||
| 2017 | -10.39% | ||
| 2016 | +28.33% | ||
| 2015 | 0.00% | ||
| 2014 | 0.00% | ||
| 2013 | +200.00% | ||
| 2012 | -75.00% | ||
| 2011 | -60.00% | ||
| 2010 | -74.36% | ||
| 2009 | +160.02% | ||
| 2008 | -63.42% | ||
| 2007 | +105.00% | ||
| 2006 | -9.09% | ||
| 2005 | -71.79% | ||
| 2004 | -14.28% | ||
| 2003 | -3.19% | ||
| 2002 | -41.25% | ||
| 2001 | +3.22% |
- Stock Market
- Equities
- TRI Stock
- Quotes TrivarX Limited
